ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2293

Altered Expression of the MicroRNA Biogenesis Machinery Components Correlates with Inflammatory Parameters in Salivary Glands of Patient with Sjögren’s Disease

Sergio Aguilera1, Patricia Carvajal2, Isabel Castro2, María-José Barrera3, Sergio González4, Claudio Molina3 and María-Julieta González2, 1Clinica Indisa, Santiago, Chile, 2Universidad de Chile, Santiago, Chile, 3Universidad San Sebastián, Santiago, Chile, 4Universidad Mayor, Santiago, Chile

Meeting: ACR Convergence 2024

Keywords: Inflammation, Micro-RNA, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Sjögren's Syndrome – Basic & Clinical Science Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: MicroRNAs (miRNAs) are small non-coding RNAs involved in the regulation of gene expression at the post-transcriptional level (by translational blocking or mRNA degradation). The miRNA biogenesis involves the transcription of the primary miRNA and its processing by the multiprocessor complex (consisting of the RNAse Drosha and its cofactor DGCR8), generating the miRNA precursor (pre-miRNA). The pre-miRNAs are transported to the cytosol where the RNAse Dicer processes them. TRBP and PACT promote Dicer positioning at the 3′ end of the pre-miRNA for processing to a double strand miRNA. The mature miRNA strand is transferred to Ago proteins forming the RNA-induced silencing complex (RISC). Stressor stimuli, such as inflammatory mediators, modify the levels, localization and/or activity of key miRNA-bioprocessing core components. Previously, in labial salivary glands (LSG) of patients with Sjögren’s disease (SjD), we found altered levels of miRNAs involved in the regulation of genes essential for glandular homeostasis and secretory function. However, it is not yet known whether the alterations in the expression pattern of miRNAs in LSG from SjD patients are due to changes in their metabolic machinery induced by inflammation. Here, we characterized the expression and localization of microRNA biogenesis components in LSG from primary SjD patients and evaluated if proinflammatory cytokines modify their levels or distribution in vitro.

Methods: LSGs biopsies from 12 SjD patients and 11 non-Sjögren sicca controls were studied. Human salivary glands (HSG) cells stimulated with 10 ng/mL of TNF-a, IFN-a, IFN-b or IFN-g for 24 h were also evaluated. The mRNA and protein levels, as well as localization of Drosha, DGCR8, Dicer, TRBP, PACT, Ago1, Ago2 and Ago4 were determined by qPCR, Western blot, and immunofluorescence. Spearman’s rank correlation analyses were performed between mRNA/protein levels and clinical parameters.

Results: Our results showed reduced mRNA levels of Drosha, Dicer, PACT, TRBP and Ago1 in LSGs from SjD patients, while protein levels showed great variability among SjD patients. Decreased mRNA levels of Drosha, Dicer and TRBP were inversely correlated with focus score and EULAR SS disease activity index (ESSDAI). Drosha, DGCR8, DICER, PACT and Ago2 were detected in the cytoplasm, and TRBP was unexpectedly observed in the nuclei. In HSG cells stimulated with proinflammatory cytokines (TNF-a, IFN-a, IFN-b or IFN-g), increased mRNA and protein levels of Drosha, DGCR8, Dicer, PACT, TRBP, Ago2 and Ago4 were observed. Dicer staining was weaker in cells stimulated with IFN-b, IFN-g and TNF-a, while TRBP signal was weaker in cells stimulated with IFN-b and IFN-g.

Conclusion: Altered expression of miRNA biogenesis machinery components correlated with focus score and ESSDAI, together with alterations induced by pro-inflammatory cytokines in vitro, contribute to understand the mechanisms underlying the differential expression of miRNAs in LSGs from SjD patients. Future studies using anti-inflammatory therapies may restore miRNA metabolism improving glandular function in SjD patients. Supported by Fondecyt-ANID: 1210055, 1230852, 1241526, Fondecyt-Postdoc: 3240081, FONDEQUIP: EQM170098.


Disclosures: S. Aguilera: None; P. Carvajal: None; I. Castro: None; M. Barrera: None; S. González: None; C. Molina: None; M. González: None.

To cite this abstract in AMA style:

Aguilera S, Carvajal P, Castro I, Barrera M, González S, Molina C, González M. Altered Expression of the MicroRNA Biogenesis Machinery Components Correlates with Inflammatory Parameters in Salivary Glands of Patient with Sjögren’s Disease [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/altered-expression-of-the-microrna-biogenesis-machinery-components-correlates-with-inflammatory-parameters-in-salivary-glands-of-patient-with-sjogrens-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/altered-expression-of-the-microrna-biogenesis-machinery-components-correlates-with-inflammatory-parameters-in-salivary-glands-of-patient-with-sjogrens-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology